Corteva (CTVA US)
CTVA US$11.33
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 11.33
- Change
- ▼ -0.30 (-2.58)
- Bid / Ask
- 11.30 - 11.31
- Volume
- 8,342,573
- Turnover
- 92,462,251
- Open
- 11.63
- Day Range
- 11.25 - 11.73
- VWAP
- 11.34
- Prev Close
- 11.63
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Basic Materials
- Shares Issued
- 667,196,000
- NTA/Share
- 8.36
- Last Dividend
- 0.18
- Dividend Ex Date
- 1 SEP 2026
- Dividend Pay Date
- 15 SEP 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 17,401.00
- EBITDA
- 2,935.00
- Profit
- 1,094.00
- Earnings Per Share (EPS)
- 1.60
- Dividend Per Share (DPS)
- 0.70
- Yield %
- 6.35
- Market Cap
- 7,559.33
- Price to Earnings Ratio (P/E)
- 6.87
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 8,036.86
- EBITDA
- 1,450.00
- Profit
- 1,468.59
- Earnings Per Share (EPS)
- 2.75
- Dividend Per Share (DPS)
- 0.40
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 14.83 Fair value 17.54 One-star price 20.74
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 17.54
- Price / Fair Value
- 0.65
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (14.83) to the one-star price (20.74).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 11.33 |
| Price - 12 month high | 14.62 |
| Price - 12 month low | 9.09 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 17.61 |
| Market capitalization | 7,559.33 |
| 12 Month High price date | 7 OCT 2026 |
| 12 Month Low price date | 3 NOV 2025 |
| Volume - avg. trading volume for the last 3 months | 34.19 |
| Price - 1 Day % Change | -2.58% |
| Price - 13 week price percent change | -15.10% |
| Price - 26 week price percent change | -4.34% |
| Price - 5 Day % Change | -10.93% |
| Price - 52 week price percent change | 19.00% |
| Price - YTD price percent change | 12.09% |
| Price % Change Month To Date | -2.86% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 1.750 |
| EPS excluding extraordinary items - trailing 12 month | 1.620 |
| EPS Normalized - most recent fiscal year | 3.340 |
| Revenue/share - most recent fiscal year | 25.537 |
| Revenue/share - trailing 12 month | 26.394 |
| Book value per share - most recent fiscal year | 35.920 |
| Book value per share - most recent quarter | 37.719 |
| Book value (tangible) per share - most recent fiscal year | 8.361 |
| Book value (tangible) per share - most recent quarter | 10.435 |
| Cash per share - most recent fiscal year | 6.726 |
| Cash per share - most recent quarter | 3.546 |
| Cash Flow per share - most recent fiscal year | 4.279 |
| Cash Flow per share - trailing 12 month | 3.436 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.720 |
| EBITD per share - trailing 12 month | 4.247 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 1.750 |
| EPS Basic excluding extraordinary items - trailing 12 month | 1.630 |
| EPS including extraordinary items - most recent fiscal year | 1.600 |
| EPS including extraordinary items - trailing 12 month | 1.516 |
| Free Cash Flow per share - trailing 12 month | 2.574 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 6.99 |
| P/E Normalized, most recent fiscal year | 2.99 |
| Price to sales - most recent fiscal year | 0.43 |
| Price to Tangible Book - most fiscal year | 1.13 |
| Price to Free Cash Flow per Share - most recent fiscal year | 4.40 |
| Price to Cash Flow per share - trailing 12 month | 3.30 |
| Price to Book - most recent fiscal year | 0.30 |
| P/E excluding extraordinary items high, trailing 12 months | 55.54 |
| P/E excluding extraordinary items low, trailing 12 months | 6.99 |
| Net Debt, LFI | 2,510.00 |
| Net Debt, LFY | -1,950.00 |
| Dividend Yield - 5 Year Average | 1.04% |
| Dividend Yield - indicated annual dividend divided by closing price | 6.19% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 6.35% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 2,325.00 |
| LT debt/equity - most recent fiscal year | 6.91% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 10.58% |
| LT debt/equity - most recent quarter | 6.62% |
| Total debt/total equity - most recent quarter | 19.19% |
| Free Cash Flow - trailing 12 month | 1,737.00 |
| Payout ratio - trailing 12 month | 35.76% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 17,401.00 |
| Revenue - trailing 12 month | 17,812.00 |
| EBITD - most recent fiscal year | 2,935.00 |
| EBITD - trailing 12 month | 2,866.00 |
| Earnings before taxes - most recent fiscal year | 1,688.00 |
| Earnings before taxes - trailing 12 month | 1,583.00 |
| Net Income available to common - most recent fiscal year | 1,094.00 |
| Net Income available to common - trailing 12 months | 1,009.00 |
| Earnings before taxes Normalized - most recent fiscal year | 1,787.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | 2,276.00 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 3.79 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 6.92% |
| Net Profit Margin % - trailing 12 month | 6.16% |
| Operating margin - 1st historical fiscal year | 15.05% |
| Operating margin - trailing 12 month | 17.08% |
| Pretax margin - trailing 12 month | 8.89% |
| Pretax margin - 1st historical fiscal year | 9.70% |
| Operating Margin - 5 year average | 11.83% |
| Pretax Margin - 5 year average | 9.35% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 11.52% |
| Free Operating Cash Flow/Revenue, TTM | 9.75% |
| Net Profit Margin - 5 year average | 7.22% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 2.87% |
| Return on average assets - trailing 12 month | 2.60% |
| Return on average equity - most recent fiscal year | 4.88% |
| Return on average equity - trailing 12 month | 4.40% |
| Return on average assets - 5 year average | 2.99% |
| Return on average equity - 5 year average | 5.06% |
| Net Income/employee - most recent fiscal year | 56,000.00 |
| Revenue/employee - most recent fiscal year | 809,348.84 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 4.12% |
| EPS growth rate, 5 year | 11.95% |
| Growth rate% - dividend, 3 year | 6.47% |
| Revenue/share (5 yr growth) | 6.18% |
| Growth rate% - Revenue, 3 year | -0.10% |
| Growth rate% - EPS, 3 year | 0.42% |
| Book value per share growth rate, 5 year | 1.47% |
| Capital Spending growth rate, 5 year | 4.47% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 9.75% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Corteva is a crop protection pure play. The company was formed in 2019 when it was spun off from DowDuPont and spun off its seeds business, Vylor, in 2026. Corteva is a leader in the development of new crop protection products, including herbicides, insecticides, fungicides, biologicals, and plant health products. Corteva operates globally. North America generates nearly 40% of revenue while Latin America generates over 30%.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
